Literature DB >> 20858082

Fatal cases of pandemic (H1N1) 2009 influenza despite their early antiviral treatment in Japan.

Nao Nukiwa, Taro Kamigaki, Hitoshi Oshitani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858082     DOI: 10.1086/656443

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Geldanamycin Reduces Acute Respiratory Distress Syndrome and Promotes the Survival of Mice Infected with the Highly Virulent H5N1 Influenza Virus.

Authors:  Chengmin Wang; Pengpeng Liu; Jing Luo; Hua Ding; Yan Gao; Lei Sun; Fubing Luo; Xiaodong Liu; Hongxuan He
Journal:  Front Cell Infect Microbiol       Date:  2017-06-15       Impact factor: 5.293

2.  Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.

Authors:  Paula E Miller; Aksharananda Rambachan; Roderick J Hubbard; Jiabai Li; Alison E Meyer; Peter Stephens; Anthony W Mounts; Melissa A Rolfes; Charles R Penn
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

3.  The value of radiographic findings for the progression of pandemic 2009 influenza A/H1N1 virus infection.

Authors:  Takanori Funaki; Kensuke Shoji; Nobuyuki Yotani; Tomohiro Katsuta; Osamu Miyazaki; Shunsuke Nosaka; Hidekazu Masaki; Akihiko Saitoh
Journal:  BMC Infect Dis       Date:  2013-11-04       Impact factor: 3.090

4.  The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-2010 influenza A virus subtype H1N1 pandemic.

Authors:  Fred Y Aoki; Frederick G Hayden
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

Review 5.  Antiviral combinations for severe influenza.

Authors:  Jake Dunning; J Kenneth Baillie; Bin Cao; Frederick G Hayden
Journal:  Lancet Infect Dis       Date:  2014-09-08       Impact factor: 25.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.